Evofem Biosciences
EVFM
$0.01675
Share price
17.96%
Change (1 day)
-16.25%
Change (1 year)
Categories
Evofem Biosciences (EVFM) - Total assets
Total assets on the balance sheet as of December 2023 : $10.55 M
According to Evofem Biosciences 's latest financial reports the company's total assets are $10.55 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Evofem Biosciences - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $25.16 M | -40.81% |
| 2021-12-31 | $42.51 M | -61.34% |
| 2020-12-31 | $0.10 B | 288.65% |
| 2019-12-31 | $28.29 M | 605.61% |
| 2018-12-31 | $4.01 M | 1.47% |
| 2017-12-31 | $3.95 M | -69.17% |
| 2016-12-31 | $12.81 M | -68.05% |
| 2015-12-31 | $40.11 M | -47.84% |
| 2014-12-31 | $76.89 M | 1597.43% |
| 2013-12-31 | $4.53 M | -64.67% |
| 2012-12-31 | $12.82 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $2.01 B | 18,961.02% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $22.68 M | 114.92% | 🇺🇸 USA |